- Home
- ELMD vs ACRS Comparison
ELMD vs ACRS Comparison
Compare ELMD & ACRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELMD
- ACRS
- Stock Information
- Founded
- ELMD 1992
- ACRS 2012
- Country
- ELMD United States
- ACRS United States
- Employees
- ELMD N/A
- ACRS N/A
- Industry
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ACRS Biotechnology: Pharmaceutical Preparations
- Sector
- ELMD Health Care
- ACRS Health Care
- Exchange
- ELMD Nasdaq
- ACRS Nasdaq
- Market Cap
- ELMD 206.5M
- ACRS 198.2M
- IPO Year
- ELMD 2010
- ACRS 2015
- Fundamental
- Price
- ELMD $25.15
- ACRS $1.86
- Analyst Decision
- ELMD Strong Buy
- ACRS Strong Buy
- Analyst Count
- ELMD 2
- ACRS 9
- Target Price
- ELMD $35.50
- ACRS $9.25
- AVG Volume (30 Days)
- ELMD 81.2K
- ACRS 1.1M
- Earning Date
- ELMD 11-11-2025
- ACRS 11-05-2025
- Dividend Yield
- ELMD N/A
- ACRS N/A
- EPS Growth
- ELMD 46.55
- ACRS N/A
- EPS
- ELMD 0.85
- ACRS N/A
- Revenue
- ELMD $64,000,000.00
- ACRS $16,789,000.00
- Revenue This Year
- ELMD $14.47
- ACRS N/A
- Revenue Next Year
- ELMD $10.33
- ACRS $7.02
- P/E Ratio
- ELMD $29.49
- ACRS N/A
- Revenue Growth
- ELMD 16.97
- ACRS N/A
- 52 Week Low
- ELMD $17.73
- ACRS $1.05
- 52 Week High
- ELMD $35.56
- ACRS $5.17
- Technical
- Relative Strength Index (RSI)
- ELMD 59.43
- ACRS 48.24
- Support Level
- ELMD $23.98
- ACRS $1.81
- Resistance Level
- ELMD $24.90
- ACRS $1.94
- Average True Range (ATR)
- ELMD 0.83
- ACRS 0.10
- MACD
- ELMD -0.11
- ACRS -0.02
- Stochastic Oscillator
- ELMD 88.94
- ACRS 26.83
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About ACRS Aclaris Therapeutics Inc.
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.